To protect the public from the unprofessional, incompetent, or impaired practice of medicine.
The Board of Medicine issues licenses to qualified Allopathic and Osteopathic physicians and physician assistants based on nationally recognized credentialing standards. The Board regulates the minimum standards for professional conduct and continued competence and takes disciplinary action against licensees who fail to meet these standards.
The Board approved emergency rules regarding opioid prescribing at its meeting on November 4, 2015. These rules do not apply to cancer patients or patients receiving palliative care.
Use of a morphine dose equivalent calculator is recommended for prescribers of opioids.
1. An informed consent with specific elements. The Board does not endorse a specific informed consent, but samples can be found on the NH Medical Society website, and The National Institute on Drug Abuse website.
2. A risk assessment with specific elements. The Board does not endorse a specific risk assessment tool, but samples can be found on the NH Medical Society website, American Academy of Pain Medicine website and the Washington State Agency Medical Directors’ Group.
3. A written pain agreement. The Board does not endorse a specific pain agreement, but samples can be found on the NH Medical Society website and the Washington State Agency Medical Directors’ Group.
4. Appropriate toxicology screens.
These licensees must also adhere to the principles outlined in the Federation of State Medical Boards Model Policy on the Use of Opioid Analgesics in the Treatment of Chronic Pain.
For questions or concerns, please contact Sarah Blodgett at (603) 271-6985 or email@example.com.
• The Board has issued a Statement on Naloxone Prescribing , informing licensees of the authority to engage in third party prescribing and standing orders for this drug.
• The Board, in conjunction with the Department of Justice, is providing a sample Naloxone Standing Order Form . Individual licensees may wish to consult with their own legal counsel or risk management prior to issuing a standard order.
• Frequently asked questions about Naloxone are available for review.
• Additional information about Naloxone can be found at prescribetoprevent.com.
II. Clinical Resources
• Screening, Brief Intervention and Referral to Treatment (SBIRT) is a strategy in the healthcare sector for reinforcing healthy behaviors, identifying problematic drug and alcohol use early, reducing substance misuse, and referring to treatment those who need it. This evidence based practice is a process with three main elements - Screening, Brief Intervention, and Referral to Treatment in medical settings.
• The NH Prescription Drug Monitoring Program offers prescribers and pharmacists a valuable tool for improving both patient care and the health and safety of our communities. By taking advantage of this resource, prescribers will not only better manage patients' health and prescription usage, but also promote public health and safety through the prevention and treatment for controlled substance abuse, and assist in the reduction of the diversion of controlled substances.
• The Federation of State Medical Boards offers a free CME entitled Extended-Release and Long-Acting Opioids: Assessing Risks, Safe Prescribing.
• The Massachusetts Medical Society offers a free Opioid Prescribing Series for CME credit.
III. Treatment Tools
• Buprenorphine providers are available to assist patients in need of medication assisted treatment for a substance use disorder.
• Find providers offering withdrawal management, outpatient counseling, residential treatment, recovery supports and other types of services for people experiencing problems with alcohol and other drug use, including addiction.
• Additional resources for providers and patients can be found at drugfreenh.gov.